China Biologic Products Schedules Conference Call to Discuss Second Quarter 2010 Results

PRNewswire
Aug 12, 2010

TAI'AN, China, Aug. 12 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO) (the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 8:00 a.m. Eastern Daylight Time on Monday, August 16, 2010, to discuss its second quarter 2010 results.

Hosting the call will be Mr. Colin Zhao, its Chief Executive Officer, and Mr. Tristan Kuo, its Chief Financial Officer. The Company plans to distribute its earnings press release prior to the call.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 877-409-5468. International callers should dial +1-702-894-2400. Please refer to conference ID 94191315.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Monday, August 16, 2010 at 9:00 a.m. EDT. To access the replay, dial 800-642-1687, international callers should dial +1-706-645-9291, and enter conference ID 94191315.

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state-owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. Please see the Company's website http://www.chinabiologic.com/ for additional information.

  For more information, please contact:

  Company Contact:

   Mr. Y. Tristan Kuo
   Chief Financial Officer
   China Biologic Products, Inc.
   Tel:   +86-538-6202206
   Email: IR@chinabiologic.com
   Web:   http://www.chinabiologic.com/

  Investor Relations Contact:

   Ms. Kalle Ahl, Account Manager
   CCG Investor Relations
   Phone: +1-646-833-3417
   Email: kalle.ahl@ccgir.com
   Web:   http://www.ccgirasia.com/

   Mr. Crocker Coulson, President
   Phone: +1-646-213-1915
   Email: crocker.coulson@ccgir.com

SOURCE: China Biologic Products, Inc.

CONTACT: Company Contact: Mr. Y. Tristan Kuo, Chief Financial Officer,
China Biologic Products, Inc. at +86-538-6202206 or IR@chinabiologic.com;
Investor Relations Contact: Mr. Kalle Ahl, Account Manager, CCG Investor
Relations at +1-646-833-3417 or kalle.ahl@ccgir.com; Mr. Crocker Coulson,
President, CCG Investor Relations at +1-646-213-1915 or
crocker.coulson@ccgir.com

Web site: http://www.chinabiologic.com/
http://www.ccgirasia.com/